Home » Topics » Conferences

Conferences
RSS

AIDS dementia reversed by highly active antiretroviral therapy

Sep. 25, 1997

Short-term efficacy and safety of T-20 in HIV infection

Sep. 25, 1997

Oxandrolone + glutamine for HIV-associated wasting

Sep. 25, 1997

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

Sep. 24, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Abbott searches for squalene synthase inhibitors as hypolipidemics

Sep. 23, 1997

Levormeloxifene preclinical and clinical data presented

Sep. 22, 1997

Eisai presents novel potential antipsychotic agent

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...